|
Market Closed -
Nasdaq
21:00:00 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 36.85 USD | -1.47% |
|
-4.78% | +3.74% |
| 08-10 | Cogent Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-10 | Cogent Biosciences Q2 Loss Widens | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
COGT 36.85 $
-1.47%
46.04M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| COGT | 36.85USD | -1.47% | 46.04M $ | |
CBOE
| COGT | 36.83USD | -1.50% | 1.29M $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 39.3 | 42.84 | 42.39 |
| Spread/Res. | -6.23% | -13.98% | -13.07% |
| Spread/Supp. | +4.15% | +18.79% | +63.59% |
| Support | 35.38 | 31.02 | 22.53 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- COGT Stock
- Charts Cogent Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
